More news from SABCS 2026
-
Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer
David Cescon, MD, PhD, will moderate a session on the use of circulating tumor DNA (ctDNA) tests to detect molecular or minimal residual disease (MRD).
-
Clinical controversies session to examine evolving treatment approaches in early breast cancer
Kelly Hunt, MD, will moderate a panel discussion addressing emerging treatment strategies for smaller, hormone receptor-positive breast cancers.
-
Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes
Jennifer A. Ligibel, MD, will moderate a special session that will outline preliminary findings and unanswered questions about the potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in breast cancer prevention and control.
Patient Advocacy Spotlight
-

Patient advocacy at SABCS: Partnering for progress in breast cancer research
One of the San Antonio Breast Cancer Symposium’s most unique elements is its commitment to giving a platform to patients living with the disease, as well as knowledgeable advocates, throughout its programming.
-

Visit the SABCS Patient Advocacy Pavilion
The Patient Advocacy Pavilion is a dedicated space in the SABCS Exhibit Hall that fosters connection, collaboration, and education around patient-centered breast cancer care.
-

Panel to discuss integrating lifestyle medicine into breast cancer care
Tara Sanft, MD, will moderate a special session detailing the science behind lifestyle medicine and its impact on the long-term care of patients with breast cancer.






